In the last 12 months, insiders at FILANA THERAPEUTICS, INC. ($FLNA) filed 59 transactions with the SEC: 9 open-market purchases totaling $1,231,784 and 3 sales totaling $253,948. Net insider sentiment: net buying.
FILANA THERAPEUTICS, INC. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- Barry Richard (Director) — 4 transactions totaling $3,873,870
- ROBERTSON SANFORD (Director) — 7 transactions totaling $1,518,000
- Barry Richard (President & CEO) — 9 transactions totaling $1,166,904
- Schoen Eric (Chief Financial Officer) — 11 transactions totaling $330,468
- Kupiec James William (Chief Medical Officer) — 6 transactions totaling $48,480
View all SEC Filings for FILANA THERAPEUTICS, INC. (FLNA).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov. 24, 2025 | Anderson Robert Eugene Jr | Director | P | Common Stock | 8600 | $2.90 | 8,600.0000 | 48,308,000 | 9999.99% | 0.02% |
| Nov. 20, 2025 | Barry Richard | President & CEO | P | Common Stock | 150000 | $2.76 | 938,060.0000 | 48,308,000 | 19.03% | 0.31% |
| Nov. 19, 2025 | Barry Richard | President & CEO | P | Common Stock | 73385 | $2.75 | 788,060.0000 | 48,308,000 | 10.27% | 0.15% |
| Oct. 21, 2025 | Bir Dawn Carter | Director | A | Stock Option (Right to Buy) | 53000 | $0.00 | 53,000.0000 | 48,308,000 | 9999.99% | 0.11% |
| Sept. 30, 2025 | Cook Robert Christopher | Chief Operating & Legal Office | P | Common Stock | 13725 | $2.91 | 13,725.0000 | 46,329,000 | 9999.99% | 0.03% |
| Sept. 22, 2025 | Barry Richard | President & CEO | P | Common Stock | 7172 | $2.28 | 714,675.0000 | 46,329,000 | 1.01% | 0.02% |
| Sept. 18, 2025 | Barry Richard | President & CEO | P | Common Stock | 185233 | $2.24 | 660,195.0000 | 46,329,000 | 39.00% | 0.40% |
| Sept. 18, 2025 | Barry Richard | President & CEO | P | Common Stock | 5400 | $2.13 | 474,962.0000 | 46,329,000 | 1.15% | 0.01% |
| Sept. 19, 2025 | Barry Richard | President & CEO | P | Common Stock | 46908 | $2.29 | 707,503.0000 | 46,329,000 | 7.10% | 0.10% |
| Sept. 19, 2025 | Barry Richard | President & CEO | P | Common Stock | 400 | $2.25 | 660,595.0000 | 46,329,000 | 0.06% | 0.00% |
| May 23, 2025 | SCANNON PATRICK J MD PHD | Director | A | Stock Option (Right to Buy) | 26500 | $0.00 | 26,500.0000 | 46,329,000 | 9999.99% | 0.06% |
| May 23, 2025 | Anderson Robert Eugene Jr | Director | A | Stock Option (Right to Buy) | 26500 | $0.00 | 26,500.0000 | 46,329,000 | 9999.99% | 0.06% |
| May 23, 2025 | O DONNELL MICHAEL J | Director | A | Stock Option (Right to Buy) | 26500 | $0.00 | 26,500.0000 | 46,329,000 | 9999.99% | 0.06% |
| May 23, 2025 | Nicaise Claude | Director | A | Stock Option (Right to Buy) | 26500 | $0.00 | 26,500.0000 | 46,329,000 | 9999.99% | 0.06% |
| May 23, 2025 | Gravier Pierre | Director | A | Stock Option (Right to Buy) | 26500 | $0.00 | 26,500.0000 | 46,329,000 | 9999.99% | 0.06% |
| May 23, 2025 | GUSSIN ROBERT Z | Director | A | Stock Option (Right to Buy) | 26500 | $0.00 | 26,500.0000 | 46,329,000 | 9999.99% | 0.06% |
| April 17, 2025 | Barry Richard | President & CEO | A | Stock Option (Right to Buy) | 350000 | $0.00 | 350,000.0000 | 46,329,000 | 9999.99% | 0.76% |
| April 17, 2025 | Schoen Eric | Chief Financial Officer | A | Stock Option (Right to Buy) | 100000 | $0.00 | 100,000.0000 | 46,329,000 | 9999.99% | 0.22% |
| April 17, 2025 | Nassif Freda | Chief Business Officer | A | Stock Option (Right to Buy) | 100000 | $0.00 | 100,000.0000 | 46,329,000 | 9999.99% | 0.22% |
| April 17, 2025 | Cook Robert Christopher | Chief Operating & Legal Office | A | Stock Option (Right to Buy) | 100000 | $0.00 | 100,000.0000 | 46,329,000 | 9999.99% | 0.22% |
| Nov. 29, 2024 | Schoen Eric | Chief Financial Officer | M | Stock Option (Right to Buy) | 50000 | $0.00 | 0.0000 | 47,976,000 | 100.00% | 0.10% |
| Nov. 29, 2024 | Kupiec James William | Chief Medical Officer | S | Common Stock | 4000 | $3.87 | 0.0000 | 47,976,000 | 100.00% | 0.01% |
| Nov. 29, 2024 | Schoen Eric | Chief Financial Officer | M | Common Stock | 50000 | $1.18 | 71,300.0000 | 47,976,000 | 234.74% | 0.10% |
| Nov. 29, 2024 | Schoen Eric | Chief Financial Officer | S | Common Stock | 2000 | $3.82 | 11,500.0000 | 47,976,000 | 14.81% | 0.00% |
| Nov. 29, 2024 | Schoen Eric | Chief Financial Officer | S | Common Stock | 59800 | $3.86 | 11,500.0000 | 47,976,000 | 83.87% | 0.12% |
| Nov. 18, 2024 | Nassif Freda | Chief Commercial Officer | A | Stock Option (Right to Buy) | 100000 | $0.00 | 100,000.0000 | 47,976,000 | 9999.99% | 0.21% |
| Nov. 18, 2024 | Landen Jaren | Chief Clinical Dev. Officer | A | Stock Option (Right to Buy) | 85000 | $0.00 | 85,000.0000 | 47,976,000 | 9999.99% | 0.18% |
| Oct. 1, 2024 | Barry Richard | President & CEO | A | Stock Option (Right to Buy) | 600000 | $0.00 | 600,000.0000 | 47,976,000 | 9999.99% | 1.25% |
| Sept. 6, 2024 | Kupiec James William | Chief Medical Officer | A | Stock Option (Right to Buy) | 100000 | $0.00 | 100,000.0000 | 41,932,000 | 9999.99% | 0.24% |
| Sept. 6, 2024 | Cook Robert Christopher | SVP & General Counsel | A | Stock Option (Right to Buy) | 100000 | $0.00 | 100,000.0000 | 41,932,000 | 9999.99% | 0.24% |
| Sept. 6, 2024 | Schoen Eric | Chief Financial Officer | A | Stock Option (Right to Buy) | 100000 | $0.00 | 100,000.0000 | 41,932,000 | 9999.99% | 0.24% |
| May 20, 2024 | BARBIER REMI | President & CEO | A | Stock Option (Right to Buy) | 50000 | $0.00 | 50,000.0000 | 41,932,000 | 9999.99% | 0.12% |
| May 20, 2024 | Schoen Eric | Chief Financial Officer | A | Stock Option (Right to Buy) | 25000 | $0.00 | 25,000.0000 | 41,932,000 | 9999.99% | 0.06% |
| May 20, 2024 | Cook Robert Christopher | SVP & General Counsel | A | Stock Option (Right to Buy) | 10000 | $0.00 | 10,000.0000 | 41,932,000 | 9999.99% | 0.02% |
| May 20, 2024 | Kupiec James William | Chief Medical Officer | A | Stock Option (Right to Buy) | 10000 | $0.00 | 10,000.0000 | 41,932,000 | 9999.99% | 0.02% |
| May 16, 2024 | ROBERTSON SANFORD | Director | G | Common Stock | 5000 | $0.00 | 1,135,851.0000 | 41,932,000 | 0.44% | 0.01% |
| May 16, 2024 | ROBERTSON SANFORD | Director | G | Common Stock | 5000 | $0.00 | 1,135,851.0000 | 41,932,000 | 0.44% | 0.01% |
| May 9, 2024 | SCANNON PATRICK J MD PHD | Director | A | Stock Option (Right to Buy) | 10000 | $0.00 | 10,000.0000 | 41,932,000 | 9999.99% | 0.02% |
| May 9, 2024 | Anderson Robert Eugene Jr | Director | A | Stock Option (Right to Buy) | 10000 | $0.00 | 10,000.0000 | 41,932,000 | 9999.99% | 0.02% |
| May 9, 2024 | Gravier Pierre | Director | A | Stock Option (Right to Buy) | 10000 | $0.00 | 10,000.0000 | 41,932,000 | 9999.99% | 0.02% |
| May 9, 2024 | Nicaise Claude | Director | A | Stock Option (Right to Buy) | 10000 | $0.00 | 10,000.0000 | 41,932,000 | 9999.99% | 0.02% |
| May 9, 2024 | O DONNELL MICHAEL J | Director | A | Stock Option (Right to Buy) | 10000 | $0.00 | 10,000.0000 | 41,932,000 | 9999.99% | 0.02% |
| May 9, 2024 | GUSSIN ROBERT Z | Director | A | Stock Option (Right to Buy) | 15000 | $0.00 | 15,000.0000 | 41,932,000 | 9999.99% | 0.04% |
| May 9, 2024 | Barry Richard | Director | A | Stock Option (Right to Buy) | 15000 | $0.00 | 15,000.0000 | 41,932,000 | 9999.99% | 0.04% |
| May 9, 2024 | ROBERTSON SANFORD | Director | A | Stock Option (Right to Buy) | 15000 | $0.00 | 15,000.0000 | 41,932,000 | 9999.99% | 0.04% |
| April 26, 2024 | ROBERTSON SANFORD | Director | M | Common Stock Warrant | 46000 | $0.00 | 380,740.0000 | 41,932,000 | 10.78% | 0.11% |
| Jan. 3, 2024 | ROBERTSON SANFORD | Director | A | Common Stock Warrant | 354740 | $0.00 | 426,740.0000 | 41,932,000 | 492.69% | 0.85% |
| April 26, 2024 | ROBERTSON SANFORD | Director | M | Common Stock | 69000 | $22.00 | 1,135,851.0000 | 41,932,000 | 6.47% | 0.16% |
| Jan. 3, 2024 | ROBERTSON SANFORD | Director | A | Common Stock Warrant | 72000 | $0.00 | 380,740.0000 | 41,932,000 | 23.32% | 0.17% |
| April 23, 2024 | Barry Richard | Director | M | Common Stock Warrant | 117390 | $0.00 | 0.0000 | 41,932,000 | 100.00% | 0.28% |
| Jan. 3, 2024 | Barry Richard | Director | A | Common Stock Warrant | 117390 | $0.00 | 176,085.0000 | 41,932,000 | 200.00% | 0.28% |
| April 23, 2024 | Barry Richard | Director | M | Common Stock | 176085 | $22.00 | 469,562.0000 | 41,932,000 | 60.00% | 0.42% |
| April 18, 2024 | Kupiec James William | Chief Medical Officer | M | Common Stock Warrant | 1000 | $0.00 | 0.0000 | 41,932,000 | 100.00% | 0.00% |
| April 18, 2024 | Kupiec James William | Chief Medical Officer | M | Common Stock | 1500 | $22.00 | 4,000.0000 | 41,932,000 | 60.00% | 0.00% |
| Jan. 3, 2024 | Kupiec James William | Chief Medical Officer | A | Common Stock Warrant | 1000 | $0.00 | 1,000.0000 | 41,932,000 | 9999.99% | 0.00% |
| Jan. 3, 2024 | Schoen Eric | Chief Financial Officer | A | Common Stock Warrant | 7920 | $0.00 | 8,720.0000 | 41,932,000 | 990.00% | 0.02% |
| April 17, 2024 | Schoen Eric | Chief Financial Officer | M | Common Stock | 1500 | $22.00 | 23,300.0000 | 41,932,000 | 6.88% | 0.00% |
| April 17, 2024 | Schoen Eric | Chief Financial Officer | M | Common Stock Warrant | 1000 | $0.00 | 7,720.0000 | 41,932,000 | 11.47% | 0.00% |
| Jan. 3, 2024 | Schoen Eric | Chief Financial Officer | A | Common Stock Warrant | 800 | $0.00 | 7,720.0000 | 41,932,000 | 11.56% | 0.00% |